| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 10/02/2007 | US7276245 Administering a botulinum toxin |
| 10/02/2007 | US7276244 Methods of treating abnormalities of the first metatarsophalangeal joint of the foot |
| 10/02/2007 | US7276243 Nucleic acid having a sequence that is codon-optimized for high level expression in a yeast cell; proteins produced provide effective immunoprophylaxis against papillomavirus infection through neutralizing antibody and cell-mediated immunity |
| 10/02/2007 | US7276242 Fowl pox viral construct composed of a first nucleic acid molecule encoding HIV Gag and/or Pol or derivatives and a second nucleic acid molecule encoding gamma-interferon and derivatives, effective in inducing, enhancing or otherwise stimulating an immune response to Gag and/or Pol. |
| 10/02/2007 | US7276241 Anticancer agents; administering polypeptide antagonist |
| 10/02/2007 | US7276240 Antibodies to novel proteins in enteroaggregative Escherichia coli (EAEC) useful for diagnosis and therapy of EAEC infections |
| 10/02/2007 | US7276239 Recombinant A2-specific TNFα-specific antibodies |
| 10/02/2007 | US7276238 Using thymus expressed chemokine (TECK) receptor as tool in detection of modulators for prevention and treatment of inflammatory, gastrointestinal and viral diseases |
| 10/02/2007 | US7276237 Human Mob-5 (IL-24) receptors and uses thereof |
| 10/02/2007 | US7276236 Methods of preparing immune globin and uses thereof |
| 10/02/2007 | US7276234 Introducing a fetal immature T lymphocyte transfected with the foreign DNA into a thymus that has been radiated to transiently suppress T lymphocytes, and expressing the foreign DNA in the thymus during differentiation and maturation of the fetal immature T lymphocyte to reconstitute the immune system |
| 10/02/2007 | US7276227 Obligate domain-swapped dimer of cyanovirin with enhanced anti-viral activity |
| 10/02/2007 | CA2413424C Substituted bicyclic derivatives for the treatment of abnormal cell growth |
| 10/02/2007 | CA2338551C Method of vaccination of newly hatched poultry |
| 10/02/2007 | CA2168583C Peptides for inducing cytotoxic t lymphocyte responses to hepatitis b virus |
| 10/02/2007 | CA1341552C Method of producing human-human hybridomas, the production of monoclonal and polyclonal antibodies therefrom, and therapeutic use thereof |
| 09/30/2007 | CA2541701A1 Use of streptococcus suis 38 kda polypeptide as an immunogen |
| 09/27/2007 | WO2007109742A2 Methods for humanizing antibodies and humanized antibodies made thereby |
| 09/27/2007 | WO2007109686A2 Immunomodulation of inflammatory conditions utilizing follistatin-like protein-1 and agents that bind thereto |
| 09/27/2007 | WO2007109583A2 Compositions and methods for prevention or treatment of neoplastic disease in a mammalian subject |
| 09/27/2007 | WO2007109567A1 Anti-tat226 antibodies and immunoconjugates |
| 09/27/2007 | WO2007109564A2 Yeast cell particles as oral delivery vehicles for antigens |
| 09/27/2007 | WO2007109360A2 Tem8 as an adjuvant and uses thereof |
| 09/27/2007 | WO2007109307A2 Antibodies directed to angiopoietin-like protein 4 and uses thereof |
| 09/27/2007 | WO2007109254A2 Stabilized polypeptide compositions |
| 09/27/2007 | WO2007109221A2 Methods for reducing protein aggregation |
| 09/27/2007 | WO2007109196A2 Method, system and program for tracking pharmaceutical samples |
| 09/27/2007 | WO2007109129A2 Methods for preparing complex multivalent immunogenic conjugates |
| 09/27/2007 | WO2007109052A2 Methods of treating lupus using cd4 antibodies |
| 09/27/2007 | WO2007108903A2 Campylobacter vaccines and methods of use |
| 09/27/2007 | WO2007108829A2 Tuberculosis nucleic acids, polypeptides and immunogenic compositions |
| 09/27/2007 | WO2007108808A1 Vaccine for a therapeutic or a prophylactic treatment of myasthenia gravis |
| 09/27/2007 | WO2007108756A1 Improved protofibril selective antibodies and the use thereof |
| 09/27/2007 | WO2007108633A1 A pharmaceutical composition for the treatment or prevention of allergic diseases, use thereof, and a method for treatment or prevention of allergic diseases |
| 09/27/2007 | WO2007108568A1 Hn epitope recognized by avian immune system and antigenic variant newcastle disease viruses carrying changes in the epitope |
| 09/27/2007 | WO2007108559A1 Agonistic antibody directed against human thrombopoietin receptor |
| 09/27/2007 | WO2007108557A1 Control of intracellular target molecule by ip3 receptor-binding protein |
| 09/27/2007 | WO2007108152A1 High functional bispecific antibody |
| 09/27/2007 | WO2007107770A1 Anti-inflammatory proteins and improved vaccines |
| 09/27/2007 | WO2007107764A1 Reversibly inhibited antibodies for immune cell stimulation |
| 09/27/2007 | WO2007107739A1 Adjuvant |
| 09/27/2007 | WO2007107585A1 Intranasal influenza vaccine based on virosomes |
| 09/27/2007 | WO2007107488A2 Vaccine against trypanosoma cruzi infection |
| 09/27/2007 | WO2007107349A1 Antibody specific for human il-4 for the treament of cancer |
| 09/27/2007 | WO2007107329A1 Tumor therapy with an antibody for vascular endothelial groeth factor and an antibody for human epithelial growth factor receptor type 2 |
| 09/27/2007 | WO2007087064A8 Pneumococcal serotypes |
| 09/27/2007 | WO2007081790A3 Methods for diagnosing and treating prostate cancer |
| 09/27/2007 | WO2007062371A3 Live vector vaccine and uses thereof |
| 09/27/2007 | WO2007053182A3 Plant produced vaccine for amebiasis |
| 09/27/2007 | WO2007047907A3 Dek protein compositions and methods of using the same |
| 09/27/2007 | WO2007024705A3 Method of treating depression using a tnf-alpha antibody |
| 09/27/2007 | WO2005099751A3 Apparatus and method for transdermal delivery of influenza vaccine |
| 09/27/2007 | WO2005046583A3 Modified fviii having reduced immunogenicity through mutagenesis of a2 and c2 epitopes |
| 09/27/2007 | WO2004073504A3 Methods for the treatment and prevention of diseases of biological conduits |
| 09/27/2007 | US20070225242 Method and composition for treating and preventing tumor metastasis in vivo |
| 09/27/2007 | US20070225222 Use of heparin-binding domain of fibronectin for diagnosis and treatment of cancer |
| 09/27/2007 | US20070225210 Therapeutic vaccine compositions for the treatment of type 1 diabetes |
| 09/27/2007 | US20070225207 Group 1 Mite Polypeptide Variants |
| 09/27/2007 | US20070224225 Immune Response Stimulating Composition Comprising Nanoparticles Based on a Methyl Vinyl Ether-Maleic Acid Copolymer |
| 09/27/2007 | US20070224224 Protozoan Strains of Reduced Virulence and Use Thereof |
| 09/27/2007 | US20070224223 Methods for the in vitro culture of sporozoea sp. and uses thereof |
| 09/27/2007 | US20070224222 Neisserial Vaccines |
| 09/27/2007 | US20070224221 Botulinum toxin neurotoxic component for treating juvenile cerebral palsy |
| 09/27/2007 | US20070224220 Intranasal or inhalational administration of virosomes |
| 09/27/2007 | US20070224219 dsRNAs as influenza virus vaccine adjuvants or immuno-stimulants |
| 09/27/2007 | US20070224218 Viral antigens |
| 09/27/2007 | US20070224217 Virulence genes of M. marinum and M. tuberculosis |
| 09/27/2007 | US20070224212 for therapeutic treatment against HIV infection by inhibiting the virus-host cell membrane fusion process; inhibitors of HIV infectivity |
| 09/27/2007 | US20070224211 HIV-1 glycopeptides and derivatives; preparation and applications thereof |
| 09/27/2007 | US20070224210 Immunostimulatory nucleic acids |
| 09/27/2007 | US20070224209 Therapeutic uses of glandular kallikrein |
| 09/27/2007 | US20070224208 Ras mutation and compositions and methods related thereto |
| 09/27/2007 | US20070224207 Reagents and methods for cancer treatment and prevention |
| 09/27/2007 | US20070224206 Inactivating Organisms Using Carbon Dioxide at or Near its Supercritical Pressure and Temperature Conditions |
| 09/27/2007 | US20070224205 Compositions that include hemagglutinin, methods of making and methods of use thereof |
| 09/27/2007 | US20070224204 Combination therapy of respiratory diseases using antibodies and anti-inflammatory agents |
| 09/27/2007 | US20070224203 Tumor therapy with an antibody for vascular endothelial growth factor and an antibody for human epithelial growth factor receptor type 2 |
| 09/27/2007 | US20070224202 contains the idiotype of the HE2 antibody directed against the cellular membrane antigen Ep-CAM |
| 09/27/2007 | US20070224201 Maytansinoid conjugated immunoglobulin for use in prevention, detection and treatment of cell proliferative disorders |
| 09/27/2007 | US20070224200 Gm3 Synthase as a Therapeutic Target in Microvascular Complications of Diabetes |
| 09/27/2007 | US20070224199 Targeting of MKRN1 for Identifying Cancer Treatment Agents |
| 09/27/2007 | US20070224198 Antithrombotic agents |
| 09/27/2007 | US20070224197 Three-dimensional structure of complement receptor type 2 and uses thereof |
| 09/27/2007 | US20070224196 Immunogenicity-reduced anti-cr1 antibody and compositions and methods of treatment based thereon |
| 09/27/2007 | US20070224195 Antitumor agents; enhanced by administration of cytoxic T lymphocyte (CTLA-4) blocker and/or cytosine-guanosine (CpG) oligodeoxynucleotide immunomodulators |
| 09/27/2007 | US20070224194 Methods for Inhibiting Angiogenesis and/or Lymphangiogenesis |
| 09/27/2007 | US20070224193 Methods of increasing lean tissue mass using ob protein compositions |
| 09/27/2007 | US20070224192 antibody or immunoadhesin increases binding affinity to an Fc variants; amino acid substitution; glycosylated Fc; computer aided drug design; drug target |
| 09/27/2007 | US20070224191 Methods of treatment of Ulcerative Colitis and Crohn's disease with anti-CD3 antibodies |
| 09/27/2007 | US20070224190 Anti-amyloid immunogenic compositions, methods and uses |
| 09/27/2007 | US20070224189 CD20 OPTIMIZED Fc VARIANTS AND METHODS FOR THEIR GENERATION |
| 09/27/2007 | US20070224188 humanized anti-CD20 antibodies comprising a human IgG1 Fc region; for treating lymphoma |
| 09/27/2007 | US20070224187 Method of treating a pathological syndrome and a pharmaceutical agent |
| 09/27/2007 | US20070224185 Secreted and Transmembrane Polypeptides and Nucleic Acids Encoding the Same |
| 09/27/2007 | US20070224174 Natural killer cell compositions and method for production of the same |
| 09/27/2007 | US20070224166 Uses of mammalian cytokine; related reagents |
| 09/27/2007 | US20070224125 Polypeptide of given sequence; transforming or transfecting cell with expression vector; inhibits tumor necrosis factor release; anti-inflammatory |
| 09/27/2007 | US20070224123 Proteins expressed by mycobacterium tuberculosis and not by bcg and their use as diagnostic reagents and vaccines |
| 09/27/2007 | US20070224122 Method of in vitro diagnosis which discriminates between exposure of a subject to Mycobacterium tuberculosis and vaccination with Bacille Calmette Guerin strain of Mycobacterium bovis, method comprising testing for presence of CD4 T lymphocytes that respond to MTBN4 |
| 09/27/2007 | US20070224118 Methods for soluble zalpha11 cytokine receptors |